These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3678595)

  • 1. Absolute and relative bioavailability of a slow release theophylline preparation in asthmatic children.
    Boner AL; De Stefano G; Vallone G; Plebani M; Ventura P
    J Int Med Res; 1987; 15(5):282-92. PubMed ID: 3678595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
    McKenzie S; Baillie E
    J Int Med Res; 1979; 7 Suppl 1():22-7. PubMed ID: 437305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations.
    McKenzie S; Baillie E
    Arch Dis Child; 1978 Dec; 53(12):943-6. PubMed ID: 747398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
    Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
    Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from intravenous to sustained-release oral theophylline in pediatric patients with asthma.
    Clarke DF; Werbowsky OL; Grodin MA; Shargel L
    Drug Intell Clin Pharm; 1986 Sep; 20(9):700-3. PubMed ID: 3757784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring of three delayed-release preparations of theophylline in the plasma of children: pharmacokinetic parameters and therapeutic significance].
    Domínguez Granados R; Pita Calandre E; Girón Caro F; Gómez Rubio M; Molina Font JA
    An Esp Pediatr; 1987 Nov; 27(5):357-61. PubMed ID: 3439657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma.
    Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Harris JB
    Ther Drug Monit; 1988; 10(4):395-400. PubMed ID: 3059587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Slow-release theophylline for the treatment of asthmatic children].
    Iwasaki E; Baba M
    Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two new controlled-release theophylline formulations in the management of asthma in children and reliability of salivary theophylline concentration.
    Boner AL; Bennati D; Miglioranzi P; Gaburro D
    J Asthma; 1986; 23(4):195-202. PubMed ID: 3531149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the plasma profiles of two slow release theophylline preparations in asthmatic patients and healthy volunteers.
    Langaker KE; Bredesen JE; Holland A
    Br J Clin Pract Suppl; 1984; 35():50-2. PubMed ID: 6433960
    [No Abstract]   [Full Text] [Related]  

  • 16. Erratic absorption of a slow-release theophylline sprinkle product.
    Pedersen S; Møller-Petersen J
    Pediatrics; 1984 Oct; 74(4):534-8. PubMed ID: 6483520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the pharmacokinetic characteristics of slow release theophylline oral preparations in Thai children with persistent asthma.
    Trakultivakorn M; Kanthawatana S; Tontayapiwat A; Jiraporncharoen K
    Asian Pac J Allergy Immunol; 1999 Dec; 17(4):255-9. PubMed ID: 10698464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions.
    Steinijans VW; Schulz HU; Böhm A; Beier W
    Eur J Clin Pharmacol; 1987; 33(5):523-6. PubMed ID: 3428347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of theophylline in children with acute asthmatic crisis].
    Casasín Edo T; Llusa Arbos M; Gómez Papi A; Closa Monasterolo R; Tarrés Roure A
    An Esp Pediatr; 1988 Sep; 29(3):220-2. PubMed ID: 3057979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Slow-release theophyllines: serum and saliva levels in asthmatic children].
    Souto Martínez I; Duque Hernández J; Galván Tudela L; Alvarez Sanz E; Díaz Gómez MI
    An Esp Pediatr; 1988 Jun; 28(6):513-6. PubMed ID: 3195854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.